Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2024

Shelley Wood

November 01, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

Presentation TCT 2024

TCT 938: Identification and Characterization of Microparticles and Microorganisms in Blood Clots of STEMI Patients: A Comparative Study of Rescue and Primary Angioplasty

Presenter: Kelly Silva

October 28, 2024

Presentation TCT 2024

A Randomized Comparison Between Selution SLR™ Sirolimus-Eluting Balloon and Plain Old Balloon Angioplasty in Patients With Distal Internal Pudendal-Penile Artery Disease and Erectile Dysfunction: The PERFECT-SELUTION First-in-Man Study

Presenter: Tzung-Dau Wang

October 28, 2024

Presentation TCT 2024

Intravascular Ultrasound-Guided Versus Angiography-Guided Drug-Coated Balloon Angioplasty in Complex Femoropopliteal Artery Disease: Primary Subgroup Analysis of the Randomized IVUS-DCB Trial

Presenter: Seung-Jun Lee

October 28, 2024

Presentation TCT 2024

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

Presenter: Sahil Parikh

October 28, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Daily News

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

L.A. McKeown

April 24, 2024

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

Presentation ACC 2024

Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease

Presenter: Young-Guk Ko

April 08, 2024

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

L.A. McKeown

March 25, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Conference News ISET 2024

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Caitlin E. Cox

January 31, 2024

News Conference News ISET 2024

Tack Works Well in Dissection Repair of Complex Lesions: TOBA II BTK

Caitlin E. Cox

January 25, 2024

Advertisement

Top Endovascular News of 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

TCTMD’s Top 10 Most Popular Stories for October 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

TCT 938: Identification and Characterization of Microparticles and Microorganisms in Blood Clots of STEMI Patients: A Comparative Study of Rescue and Primary Angioplasty

A Randomized Comparison Between Selution SLR™ Sirolimus-Eluting Balloon and Plain Old Balloon Angioplasty in Patients With Distal Internal Pudendal-Penile Artery Disease and Erectile Dysfunction: The PERFECT-SELUTION First-in-Man Study

Intravascular Ultrasound-Guided Versus Angiography-Guided Drug-Coated Balloon Angioplasty in Complex Femoropopliteal Artery Disease: Primary Subgroup Analysis of the Randomized IVUS-DCB Trial

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

What’s Going to Be Big at TCT 2024?

FDA Approves Bioresorbable Scaffold for BTK Lesions

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Tack Works Well in Dissection Repair of Complex Lesions: TOBA II BTK

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content